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Abstract
Background: The dysfunction of articular chondrocytes is a crucial step in rheumatoid arthritis (RA) pathogenesis
while its molecular mechanisms are not fully known. This study was aimed to investigate the expression of
aquaporin 4 (AQP4) in articular chondrocytes of adjuvant-induced arthritis (AIA) rats and its involvement in AIA
development.
Methods: Thirty rats were divided into normal and AIA group (n = 15). Rat AIA was induced by intradermal
injection of complete Freund’s adjuvant and evaluated by secondary paw swelling and histological assessments on
knee joint damage. Localization and protein expression of AQP4 in articular cartilage were examined by
immunohistochemistry and western blot. In vitro study, AIA articular chondrocytes were cultured and treated with
acetazolamide, an AQPs inhibitor. AQP4 protein level, cell proliferation and mRNA levels of type-II collagen (COII)
and aggrecan were measured by western blot, MTT assay and real-time PCR, respectively.
Results: The results of immunohistochemistry and western blot indicated that AQP4 showed higher protein levels
in cartilage tissues of AIA rats than that of normal rats. Correlation analysis revealed that AQP4 protein level in
cartilage tissues of AIA rats remarkably correlated positively with secondary paw swelling on day 26 after AIA
induction as well as pathological scores on joint damage. Additionally, acetazolamide treatment effectively
decreased AQP4 protein level, increased cell proliferation and mRNA levels of COII and aggrecan, suggesting AQP4
inhibition by acetazolamide could normalize the dysfunction of AIA articular chondrocytes in vitro.
Conclusions: Our data provide certain experimental evidence that AQP4 over-expression in articular chondrocytes
aggravated AIA severity and might be a novel target for RA treatment.
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Background
Rheumatoid arthritis (RA) is a chronic autoimmune in-
flammatory disease and usually causes serious disability
in affected individuals [1]. Joint swelling, synovial in-
flammation and progressive destruction of cartilage are
the hallmarks of RA [2]. Previous studies on RA patho-
genesis predominantly focus on synovial inflammation
and excessive synovial hyperplasia. However, accumulat-
ing clinical evidence reveal that the joint destruction is
not always correlated with inflammatory process in RA
[3], joint destruction still occurs even when the joint in-
flammation is suppressed by proper anti-arthritic treat-
ment [4]. Particularly, articular cartilage damage is
positively associated with irreversible RA disability, and
more attention should be taken to the molecular patho-
mechanism of articular cartilage damage in RA [5].
As the unique cellular component in cartilage, articu-
lar chondrocytes are responsible for synthesizing and
maintaining the cartilage extracellular matrix (ECM)
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which mainly consists of water, type-II collagen (COII)
and proteoglycans [6]. The metabolic activity of articular
chondrocytes is influenced by local extracellular physico-
chemical factors including pH, fluid flow, ionic and os-
motic environment [7]. In the affected joints of RA,
multiple extracellular pathological changes such as
hydrarthrosis, acidosis and hyperosmotic stress induce
the dysfunction of articular chondrocytes, e.g., excessive
apoptosis and reduced ECM synthesis ability, eventually
lead to articular cartilage destruction [8].
Aquaporins (AQPs) belong to membrane transport
proteins family and are closely involved in regulating the
influx and outflow of water and small molecules [9]. At
least 13 mammalian AQPs (AQP0-12) have been studied
in various tissues and organs including kidney, eye, brain
and lung [10]. The permeability of AQPs is dependant
on the osmotic and hydrostatic gradients and pH values
[9, 11]. Several investigations have showed underlying
involvement of AQPs in cartilage damage of joint dis-
eases such as RA and osteoarthritis (OA). Mobasheri et
al. firstly confirmed that AQP1, 3 are expressed in
equine articular cartilage [12]. AQP1 expression was
found significantly increased in articular cartilage of RA
[13, 14] and OA patients or experimentally induced OA
rats [15, 16]. Nagahara et al. observed that AQP9 was
strongly expressed in the synovial tissues of OA and RA
patients, and was related to the pathogenesis of hydrar-
throsis and synovitis [17]. It is well known that AQP4
possess very high single channel water permeability (3-
fold greater than that of AQP1) [18], while previous
studies of AQP4 mainly aim at nervous system diseases
[19]. There is high homology between human and rat
AQP4 (93%). Interestingly, our recent work suggested
that AQP4 expressed in human cartilage tissues. How-
ever, the potential pathological role of AQP4 in RA car-
tilage damage is still unknown.
In this study, rat with adjuvant-induced arthritis (AIA)
was established and used as an experimental model re-
sembling RA. We investigated the AQP4 expression in
articular cartilage of AIA rats and revealed potential in-
volvement of AQP4 activation in the development of
rats AIA. Acetazolamide is a widely used sulfonamide
carbonic anhydrase inhibitor and is recently shown to be
a potent inhibitor of AQPs [20, 21]. In vitro studies, we
observed the effects of acetazolamide on AQP4 expres-
sion, cell proliferation and mRNA levels of COII and
aggrecan in cultured AIA chondrocytes.
Methods
Animals and AIA induction
Male Sprague Dawley rats weighting 140–160 g were
purchased from Experimental Animal Center of Anhui
Medical University and housed under standardized con-
ditions of temperature (20–22 °C) and humidity (50–
60%). After 7-day acclimatization, the rats were ran-
domly divided into normal rats group and AIA experi-
mental group (15 rats per group). Commercial complete
Freund’s adjuvant (CFA) (Catalog #7027, 10 mg/mL) was
got from Chondrex, Inc (WA, USA). Each Rat in AIA
experimental group received a single intradermal injec-
tion of 0.1 mL CFA into the right hind paw to induce
arthritis [22]. Meanwhile, the equivalent volume of saline
was given to each rat in normal group.
Evaluation of arthritis development
The day of CFA injection was regarded as day 0. The vol-
ume of the non-injected (left) hind paw was measured by
a plethysmograph apparatus (YLS-7A, Academy of Med-
ical Science of Shandong Province, China) at various time
points including day 0 and day 10, 14, 18, 22, 26 after AIA
induction. The secondary paw swelling at each time point
was defined as the changes in paw volume on day 0 (basic
value) and day 10, 14, 18, 22, 26 (ΔmL).
Histopathological examination and assessment of joint
damage
Animals were euthanized on day 26 and then the left
knee joints were quickly removed, trimmed, fixed in 4%
paraformaldehyde. After decalcification in 10% EDTA
for 2 weeks, the tissues were paraffin embedded and
sliced at 5 μm thick for histopathological examination.
The paraffin sections with hematoxylin and eosin (HE)
staining were observed under a light microscope (Nikon
80i, Japan) and evaluated by two trained pathologist
blinded to the specimens. Pathological assessments of
joint damage were carried out on the basis of synovial
hyperplasia, cartilage destruction, vascular proliferation
and inflammatory cells infiltrate. Pathological scores on
the severity of lesions were classified into four grades: 0,
no detectable changes; 1, mild; 2, moderate; 3, severe.
The average of three slides per rat was used as an inde-
pendent data for statistical analysis. Total pathological
scores of joint damage were the sum of the individual
score for every pathological index.
AQP4 immunohistochemistry staining and semi-
quantitative analysis
Immunohistochemistry staining for AQP4 was per-
formed according to standard procedures [23]. The knee
joint sections were hydrated, rinsed and microwave-
treated in 0.05 M citrate-buffered saline. Sections were
treated by 3% hydrogen peroxide in methanol at room
temperature for 10 min to quench endogenous peroxid-
ase activity and incubated in 5% goat serum at 37 °C for
15 min to block nonspecific staining. Then sections were
incubated at 4 °C overnight with primary antibody of
AQP4 (1:100; Abcam plc, Cambridge, UK; Catalog
ab9512). The section of knee joint without adding AQP4
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antibody was applied as a negative control. Sections
were incubated with biotinylated secondary antibodies
and avidin-biotin horseradish peroxidase complex
(1:200; Vector Laboratories, CA, USA) at 37 °C for
30 min. Sections were visualized by diaminobenzidine,
dehydrated, hyalinized in xylene and mounted with neu-
tral gum. Finally, sections were observed by a light
microscope and typical photos were taken. Cell mem-
brane and cytoplasm contained yellow/brown granules
were considered positively stained cells. AQP4 staining
scores were determined by semi-quantitative optical ana-
lysis. The number of positive cells and total cells were
counted at five fields per slide. We calculated the posi-
tive expression rate (%), which was defined as (number
of positive cells/total cells) × 100%. The proportion of
positive cells was graded as follows [16]: (−), < 5%; (+),
5–25%; (++), 26–50%; (+++), 51–75%; (++++), > 75%.
The average of three slides was used as an independent
data for statistical analysis.
Western blot analysis
Aliquots of cartilage tissues obtained from the right knee
joints were homogenized and treated with RIPA lysis
buffer. The protein levels of lysates were measured by
Bradford assay. An equal weight of protein was sepa-
rated by SDS-PAGE and transferred onto a nitrocellu-
lose membrane. The membranes were blocked with 5%
skim milk and incubated with the primary antibodies
against AQP4 (1:500) or β-actin (1:500) at 4 °C over-
night. Subsequently, the membranes were incubated
with a horseradish peroxidase conjugated secondary
antibody at 37 °C for 2 h. The protein bands were easily
visualized using Enhanced Chemiluminescence Kit
(Pierce, IL, USA). Then the bands were scanned and
measured by ImageJ software. The ratio of optical dens-
ity value of interest protein band over its corresponding
β-actin band was recognized as the relative protein level.
Articular chondrocytes preparation and acetazolamide
treatment
Another 10 AIA rats and 10 normal rats were prepared
for the in vitro experiments. Rats were euthanized and
cartilage tissues from knee joints were quickly collected.
Articular chondrocytes were isolated and cultured simi-
lar to previously described [7, 24]. Briefly, small minced
cartilage tissues (about 1 mm3) was digested with 0.25%
trypsin for 0.5 h and 0.2% type II collagenase for 3 h in
cell incubator, respectively. The isolated cells were pipet-
ted through 200-mesh nylon mesh into centrifuge tubes
and washed with PBS. Then the freshly isolated chon-
drocytes were resuspended in DMEM medium (Thermo
Fisher Scientific, PA, USA) containing 10% fetal calf
serum (FCS), penicillin (100 IU/ml) and streptomycin
(100 μg/ml) and incubated in a flat-bottomed culture
bottle at 37 °C, 5% CO2 for 5 days. Adherent cells were
trypsinized, split and recultured in DMEM medium. The
articular chondrocytes of 1–2 passages were applied in
this study. The cultured chondrocytes were identified by
the morphological property and toluidine blue staining
of glycosaminoglycan. The cultured articular chondro-
cytes were divided into 4 groups: normal articular chon-
drocytes, AIA articular chondrocytes and AIA articular
chondrocytes treated with acetazolamide (25 or
100 μM). Acetazolamide (Sigma, MO, USA) was dis-
solved with DMSO to prepare the stock solution
(100 mM) and diluted to the final concentrations using
DMEM medium containing 10% FCS.
AQP4 expression in cultured articular chondrocytes
AQP4 immunocytochemistry staining was performed in
cultured normal and AIA chondrocytes, and the detailed
procedure of immunocytochemistry was similar to the
immunohistochemical steps described above. In
addition, we carried out western blot analysis for AQP4
in various cultured chondrocytes groups to investigate
whether acetazolamide treatment inhibited the protein
levels of AQP4 in AIA chondrocytes.
Chondrocytes proliferation measurement
Articular chondrocytes were prepared and suspended in
DMEM medium containing 10% FCS at a concentration
of 5 × 107 cells/L. 100 μL cell suspension was added to
96-well plate and incubated at 37 °C, 5% CO2 for 24 h.
After adherence, the culture medium was replaced by
200 μL DMEM or DMEM with different doses of acet-
azolamide for 48 h cultivation. 10 μL of MTT (Sigma,
MO, USA) (5 g/L) was added to each well and the cells
were incubated for another 4 h. After centrifugation, the
supernatants were removed. The formazan crystals de-
rived from MTT were dissolved completely with 150 μL
dimethyl sulfoxide per well. The absorbance (A) was
measured at 570 nm using a microplate reader and the
results were described as the average of A.
Real-Time quantitative PCR (Q-PCR) of COII and aggrecan
mRNA
Total RNA was extracted from articular chondrocytes in
various groups by Trizol method (Invitrogen, CA, USA).
cDNA were synthesized by a RevertAid First Strand
cDNA Synthesis Kit (Thermo Scientific, PA, USA). Q-
PCR was performed by SYBR Green PCR Kit (Applied
Biosystems, USA) in ABI Prism 7000 Sequence Detector.
Cycling conditions in 25 μL volume were as follows: 15 s
at 95 °C, 60 s at 64 °C (COII) or 60 °C (aggrecan); 40 cy-
cles. PCR primers were purchased from Sangon Biotech
Company (Shanghai, China): COII 5’-TCAAGTCGCT-
GAACAACCAG-3’ and 5’-GTCTCCGCTCTTCCAC
TCTG-3’; Aggrecan 5’-GCAGCACAGACACTTCAGGA-
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3’ and 5’-CCCACTTTCTACAGGCAAGC-3’; β-actin 5’-
TTGCTGACAGGATGCAGAA-3’ and 5’-ACCAATCCA-
CACAGAGTACTT-3’. The relative amplification efficien-
cies of the primers were tested and shown to be similar. 2-
ΔΔCt method was used to measure the relative amount of
mRNA and the result was normalized against β-actin.
Statistical analysis
Statistical analysis was carried out by SPSS 16.0 software.
The experimental data were analyzed by Independent-
Samples T test or One-Way ANOVA followed by LSD
post hoc test. All values were shown as mean ± standard
error of the mean (SEM) and p < 0.05 was considered to
be statistically significant. Correlation between AQP4
protein levels of AIA rats and secondary hind paw swell-
ing or pathological scores on joint damage was deter-
mined by Pearson’s correlation test.
Results
Evaluation of AIA in rats
Representative photos of non-injected hind paws in nor-
mal and AIA rats were taken on day 26 after induction
(Fig. 1a, b). AIA rats exhibited an apparent swelling of
non-injected hind paws, which was termed as secondary
inflammation (Fig. 1b). Statistical results indicated that
the secondary paw swelling of AIA rats significantly in-
creased on day 14, 18, 22 and 26 compared with normal
rats (Fig. 1c). Histopathological examinations illustrated
the severity of knee joint damage (Fig. 1 d, e). There was
no inflammation or cartilage damage in knee joint sec-
tions from normal rats (Fig. 1d). In contrast, the sections
from AIA rats exhibited many pathological features re-
sembling RA such as synovial hyperplasia, cartilage dam-
age, vascular proliferation and inflammatory cells
infiltration (Fig. 1e). The individual pathological score
for every pathological index in AIA rats was significantly
increased compared with that in normal rats (Fig. 1f ).
AQP4 was highly expressed in articular cartilage of AIA
rats
Immunohistochemistry assay was used to investigate the
localization and the relative expression levels of AQP4
in articular cartilage of rats. The typical images of AQP4
staining were shown in Fig. 2. AQP4-immunopositive ar-
ticular chondrocytes in cartilage were visibly more in
AIA rats (Fig. 2b) than those in normal rats (Fig. 2a).
The Negative control was enclosed to show the antibody
specificity (Fig. 2c). The results of statistical analysis on
AQP4 positive expression rate in cartilage tissues indi-
cated that AQP4 positive expression rate in AIA rats
was dramatically elevated than that in normal rats
(Fig. 2d). The semi-quantitative analysis result of AQP4
immunohistochemistry staining in cartilage tissues was
shown in Table 1. No strongly (++++) positive expres-
sion of AQP4 was found in normal rats, while no nega-
tive (−) expression of APQ4 in AIA rats. In addition, the
Fig. 1 Evaluation of AIA in rats. a, b Representative photos of non-injected (left) hind paw on day 26 after induction (a, Normal; b, AIA). c The changes of
secondary hind paw swelling on different time points. d, e Typical histopathological photos of knee joint sections with HE staining (×100; d, Normal; e,
AIA). In the HE fig. of knee joint from AIA rats, typical pathological characteristics resembling RA including synovial hyperplasia (dotted arrow), cartilage
damage (arrow), vascular proliferation (*) and excessive inflammatory cell infiltration could be apparently found. f Results of pathological assessments on
knee joint damage for every pathological index including synovial hyperplasia, cartilage damage, vascular proliferation and inflammatory cell infiltration.
Data are mean ± SEM (n= 15). **p< 0.01 compared with the normal group
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rate of moderately (++, +++) and strongly (++++) posi-
tive expression of AQP4 in AIA rats (12/15, 80%) was
much higher than normal rats (3/15, 20%). These fore-
mentioned findings indicated that AQP4 expression was
obviously up-regulated in articular cartilage of AIA rats.
We measured AQP4 protein levels in cartilage tissues by
western blot and typical examples of AQP4 protein expres-
sions in normal and AIA group were listed in Fig. 3a. There
existed obvious changes of AQP4 expression between nor-
mal and AIA rats. The AQP4 protein level was quantified
densitometrically by ImageJ software and β-actin was
served as a house-keeping protein (Fig. 3b). We found that
AQP4 protein levels in cartilage tissues from AIA rats were
significantly elevated as compared with normal rats.
Relationships between AQP4 protein levels and
secondary paw swelling or pathological scores on joint
damage in AIA rats
AQP4 protein levels in cartilage tissues of AIA rats sig-
nificantly correlated positively with secondary hind paw
swelling on day 26 after induction (Fig. 4a, r = 0.670, p <
0.01) and total pathological scores on knee joint damage
Fig. 2 Immunohistochemistry for AQP4 in articular cartilage of knee joints. a Normal rat (×200). b AIA rat (×200). c The negative control was
enclosed to show the antibody specificity. d AQP4 positive expression rate in articular cartilage of knee joints. The rate is defined as (number of
positive cells/total cells) × 100%. Data are mean ± SEM (n = 15). **p < 0.01 compared with the normal group
Table 1 The semi-quantitative analysis result of AQP4 immuno-
histochemistry staining in articular cartilage
Group Grade of AQP4 positive proportion
- + ++ +++ ++++
Normal 3 9 2 1 0
AIA 0 3 4 5 3
The positive proportion is graded as follows: (−), < 5%; (+), 5–25%; (++), 26–
50%; (+++), 51–75%; (++++), > 75%
Fig. 3 Western blot analyses for AQP4 in cartilage tissues. a
Representative examples of AQP4 protein expressions in cartilage
tissues of normal and AIA rats. b Semi-quantitative statistical graph
of AQP4 protein levels in cartilage tissues from knee joints of normal
and AIA rats, β-actin serves as the house-keeping protein. Data are
mean ± SEM (n = 15). **p < 0.01 compared with the normal group
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(Fig. 4b, r= 0.741, p < 0.01). The results of correlation ana-
lysis revealed that the elevated AQP4 protein levels in cartil-
age might be associated with the disease severity of AIA rats.
Cultured chondrocytes identification and AQP4
immunocytochemistry staining
The cultured cells after one passage showed a long
spindle-shaped morphology which was accordant with the
morphological property of chondrocytes (Fig. 5a). In
addition, the cultured cells were identified to be chondro-
cytes by the positive toluidine blue staining of glycosami-
noglycan (Fig. 5b). We detected the expression of AQP4
in cultured normal and AIA articular chondrocytes by im-
munocytochemistry. Consistent with our findings in vivo,
a weak AQP4 immunocytochemistry staining was ob-
served in cultured normal articular chondrocytes (Fig. 5c),
whereas a very strong AQP4 immunoreaction in cultured
AIA articular chondrocytes (Fig. 5d).
Acetazolamide inhibited AQP4 protein level in cultured
AIA chondrocytes
The AQP4 protein levels in articular chondrocytes from
various cell groups were measured by western blot
(Fig. 6a) and analyzed statistically (Fig. 6b). Similar to
our findings in vivo, AQP4 protein level in cultured AIA
articular chondrocytes was higher than that in normal
articular chondrocytes (2.1 fold). Acetazolamide treat-
ment reduced the elevated AQP4 protein level in AIA
articular chondrocytes. In addition, acetazolamide
(100 μM) caused AQP4 protein level to decrease to 63%
of the level in AIA articular chondrocytes group.
Acetazolamide induced cell proliferation of AIA articular
chondrocytes
MTT assay was applied to evaluate the potential effect
of acetazolamide on cell proliferation of cultured AIA
articular chondrocytes. As shown in Fig. 7, the cell pro-
liferation of AIA chondrocytes was lower than that of
normal chondrocytes. Acetazolamide (100 μM) treat-
ment produced a significant increase of cell proliferation
compared with AIA chondrocytes group, suggesting the
pro-proliferative effect of acetazolamide on AIA articular
chondrocytes in vitro.
Acetazolamide increased COII, aggrecan mRNA levels in
AIA chondrocytes
The mRNA levels of COII and aggrecan in various cell
groups were measured by real-time Q-PCR and analysed
statistically (Fig. 8). COII and aggrecan mRNA levels in
AIA articular chondrocytes were dramatically lower than
those in normal articular chondrocytes. Acetazolamide
(100 μM) treatment significantly increased mRNA levels
of COII and aggrecan compared with AIA articular
chondrocytes group, indicating that AQP4 inhibition by
acetazolamide could promote ECM production of AIA
articular chondrocytes in vitro.
Discussion
AIA is a classic experimental polyarthritis model resem-
bling RA and shares many pathological features of RA
such as extremities swelling, joint inflammation, synovial
hyperplasia and cartilage damage [25]. Herein, we uti-
lized rat AIA model to explore the potential pathogenic
role of AQP4 over-expression in articular chondrocytes
in RA disease progress. There are two stages in AIA pro-
gress, i.e., the primary and the secondary inflammation.
The primary inflammation stage is characterized by a
rapid onset of inflammation in the adjuvant-injected
paws within 24 h and gradually lessens after lasting
3 days. Then all paws begin to swell about on day 14
after immunization as a result of the immune response
to the bacterial adjuvant, which is called the secondary
Fig. 4 Correlations between AQP4 protein levels in cartilage tissues of AIA rats and secondary paw swelling on day 26 (a) or total pathological
scores on joint damage (b). The correlation analysis was performed by Pearson’s correlation test (n = 15). Asterisks (*) show the significance of the
correlation. **p < 0.01
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inflammation stage. The secondary inflammation is the
most sensitive parameter in exploring the pathogenesis
and the potential pharmacotherapy for RA [26, 27].
Consistent to previous studies [26, 27], in order to avoid
potential destructive severe inflammation of the
adjuvant-injected paws, we measured the volume
changes of the non-injected hind paws at the secondary
inflammation stage. In this study, we successfully estab-
lished AIA rat model by intradermal injection of CFA,
evidenced by increased secondary hind paw swelling and
aggravated severity of knee joint damage.
Articular chondrocytes are sensitive to extracellular
environment changes. In response to ionic and osmotic
stress, articular chondrocytes modify the cell shape and
cellular organization, which is mediated by cytoskeletal
reorganization and cytoplasm membrane transport
mechanisms [28]. This biological regulation is essential
for ECM homeostasis maintenance and metabolic activ-
ity [29]. As we know, AQPs are expressed in a variety of
water transporting epithelia and many other tissues
where they facilitate water transport across the cell
membrane. Since 70% of the total tissue weight in cartil-
age ECM is water [30], water transport in cartilage ECM
and the metabolic water across the membranes of chon-
drocytes may be important in both normal and patho-
logical conditions of cartilage. Interestingly, previous
studies revealed underlying involvement of AQPs
Fig. 5 Identification and AQP4 immunocytochemistry staining in cultured articular chondrocytes. a Morphology of cultured cells after one
passage (×100). b Positive toluidine blue staining of glycosaminoglycan in cultured cells (×100). c Weak AQP4 immunoreaction in cultured normal
articular chondrocytes (×400). d Strong AQP4 immunoreaction in cultured AIA articular chondrocytes (×400)
Fig. 6 Western blot analyses for AQP4 in cultured articular chondrocytes.
a Representative examples of AQP4 protein expressions in various cell
groups: normal articular chondrocytes, AIA articular chondrocytes, AIA
articular chondrocytes treated with acetazolamide (25 or 100 μM). b
Semi-quantitative statistical graph of AQP4 protein levels in various
chondrocytes groups, β-actin serves as the house-keeping protein. Data
are mean ± SEM (n= 6). **p< 0.01 compared with normal articular chon-
drocytes group. ##p< 0.01 compared with AIA articular
chondrocytes group
Fig. 7 The cell proliferation in various articular chondrocytes groups
including normal articular chondrocytes, AIA articular chondrocytes,
AIA articular chondrocytes treated with acetazolamide (25 or 100 μM).
Data are mean ± SEM (n = 6). **p < 0.01 compared with normal articular
chondrocytes group. ##p < 0.01 compared with AIA articular
chondrocytes group
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(mainly focusing on AQP1 and 3) in cartilage destruc-
tion of RA and OA [13–16]. Herein, the present study
firstly, to our knowledge, indicated the potential patho-
logic role of AQP4 over-expression in RA development,
as modeled by AIA. The results of immunohistochemis-
try and western blot indicated that AQP4 protein level
was significantly higher in cartilage tissues from AIA rats
than normal rats. Particularly, correlation analysis results
indicated that the AQP4 protein levels in cartilage tis-
sues from AIA rats correlated positively with the severity
of AIA, as determined by secondary hind paw swelling
and total pathological scores on knee joint damage. In
addition, we isolated and prepared articular chondro-
cytes from knee joints of rats, as identified by the cell
morphology and positively stain of glycosaminoglycan.
Consistent with our findings in vivo, AQP4 protein level
were significantly elevated in cultured AIA chondrocytes
compared with normal chondrocytes. These abovemen-
tioned results suggested that AQP4 was over-activated
in articular chondrocytes both in vivo and in vitro, and
might be closely related to the disease severity and pro-
gress of rats AIA.
Recently, acetazolamide is shown to be a potent inhibi-
tor of AQPs and has been extensively applied in many
vivo studies, with no obvious adverse effects or serious
toxicity [31, 32]. Many studies have revealed that acet-
azolamide could inhibit AQPs-mediated water perme-
ability in various cell types at the concentrations ranging
from 1 μM to 100 μM [20, 21, 33]. Gao J et al. found
that acetazolamide (10 and 100 μM) significantly re-
duced water osmotic permeability in HEK293 cells
transfected with pEGFP/AQP1 [20]. Yue Y et al. re-
ported that acetazolamide (100 μM) significantly
inhibited AQP1 expression in cultured fibroblast-like
synoviocytes of rheumatoid arthritis [33]. Tanimura et al.
showed that acetazolamide reversibly suppressed water
conduction by AQP4 in a dose-dependent manner and
suggested that acetazolamide might be served as a lead
compound for the development of AQP4-specific inhibi-
tors [34]. Therefore, acetazolamide was acted as a suit-
able AQPs inhibitor in the current study. Consistently,
we used the concentrations of acetazolamide (25 and
100 μM) in vitro exprements. We found that acetazol-
amide (100 μM) treatment effectively inhibited the ele-
vated AQP4 protein level in cultured AIA articular
chondrocytes.
In arthritis development such as RA and OA, articular
chondrocytes damage breaks the balance between bio-
synthesis and degradation of cartilage ECM and finally
causes progressive cartilage damage. Articular cartilage
homeostasis is the result of a complex interaction be-
tween anabolic and catabolic, anti- and pro-apoptotic,
anti- and pro-inflammatory activities. Interestingly, ar-
ticular chondrocytes death mediated by excessive apop-
tosis in cartilage has been reported in RA [35, 36] and is
considered to be an important and independent factor
contributing to RA cartilage degradation [37]. During
apoptosis, one of the earliest morphological changes is
cell shrinkage known as the apoptotic volume decrease
(AVD) [38]. Many studies have suggested that water loss
from apoptotic cells during the AVD is primarily medi-
ated by AQPs channels [39, 40]. In particular, inhibition
of AQPs-dependent water movement can inhibit the
AVD and the subsequent apoptotic events, whereas
AQPs over-expression can increase the plasma mem-
brane water permeability and the rate of apoptosis [40].
In this study, cell proliferation of cultured AIA chondro-
cytes was obviously decreased compared with normal
chondrocytes, while acetazolamide treatment effectively
increased the cell proliferation of AIA articular chondro-
cytes. Further studies should be performed to clarify
whether the pro-proliferative effect of acetazolamide on
AIA chondrocytes is mediated by inhibiting cell apop-
tosis. It is well known that proteoglycans loss through-
out ECM and disturbed collagen fibrils are typical
pathologic features of cartilage degradation in RA. COII
is the major structural collagen in cartilage and aggrecan
forms a major structural component of cartilage together
with COII. Herein, we found that acetazolamide treat-
ment reversed the reduced mRNA levels of COII and
aggrecan in cultured AIA chondrocytes, suggesting that
inhibition of AQP4 by acetazolamide might directly pro-
mote ECM production of AIA chondrocytes in vitro.
Conclusions
Taken together, the current study revealed that AQP4
was overactivated in articular chondrocytes of AIA rats
Fig. 8 COII and aggrecan mRNA levels in various chondrocytes groups
including normal articular chondrocytes, AIA articular chondrocytes and
AIA articular chondrocytes treated with acetazolamide (25 or 100 μM).
Data are mean ± SEM (n= 6). **p< 0.01 compared with normal articular
chondrocytes group. #p< 0.05, ##p< 0.01 compared with AIA articular
chondrocytes group
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and the elevated AQP4 protein levels in cartilage corre-
lated positively with the severity of AIA. Acetazolamide
treatment normalized the dysfunction of AIA chondro-
cyte in vitro, as indicated by decreasing AQP4 protein
level, inducing cell proliferation and increasing mRNA
levels of COII and aggrecan. For the first time these
findings indicate that AQP4 over-expression might be
closely involved in the pathogenesis of RA. Further in-
vestigations are needed to observe the therapeutical ef-
fect of acetazolamide on AIA and its related molecular
mechanisms.
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